NOVN Novan Inc

Novan Inc together with its subsidiaries is a North Carolina based clinical-stage drug development company. It is engaged in the development and commercialization of nitric oxide-based therapies in dermatology.

$2.33  0.00 (0.00%)
As of 06/30/2022 16:00:00 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  09/21/2016
Outstanding shares:  19,172,585
Average volume:  118,301
Market cap:   $44,672,123
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   -1.31
PB ratio:   7.52
PS ratio:   10.98
Return on equity:   -580.07%
Net income %:   -838.95%